Inactive Instrument

All News Centrexion Therapeutics Corporation

Equities

CNTX

US15643W1009

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Centrexion Therapeutics Corp. announced a financing transaction	12-27	CI
Centrexion Therapeutics Corporation announced that it has received $2.3 million in funding	11-26	CI
Centrexion Therapeutics Corporation announced that it expects to receive $2.3 million in funding	11-13	CI
Centrexion Therapeutics Corporation announces tranche update	23-07-10	CI
Centrexion Therapeutics Corporation announced a financing transaction	23-06-13	CI
Centrexion Therapeutics Corporation announced that it has received $29.14 million in funding	22-08-10	CI
Centrexion Therapeutics Corporation announced that it has received $16.475 million in funding	22-06-07	CI
Centrexion Therapeutics Corporation announced that it expects to receive $16.475 million in funding	22-05-23	CI
CONTEXT THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-11	AQ
Earnings Flash (CNTX) CONTEXT THERAPEUTICS Posts Q1 Loss $-0.22	22-05-11	MT
Context Therapeutics® Announces Encouraging Preclinical Data from Two Programs to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022	22-04-11	GL
Context Therapeutics® to Participate in Two April 2022 Investor Conferences	22-04-06	GL
CONTEXT THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	22-03-23	AQ
Context Therapeutics® Reports Full Year 2021 Operating and Financial Results	22-03-23	AQ
HC Wainwright Starts Context Therapeutics at Buy With $6 Price Target	22-02-02	MT
ThinkEquity Starts Context Therapeutics at Buy with $10 Price Target	22-01-24	MT
CONTEXT THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22-01-10	AQ
CONTEXT THERAPEUTICS INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	22-01-05	AQ
Context Therapeutics® Strengthens Research & Development Team	22-01-05	AQ
Health Care Stocks Staying On Positive Ground in Late Trade	21-12-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Centrexion Therapeutics Corporation

Equities

CNTX

US15643W1009

All News

Filters